Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.
We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.
Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.
Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.
Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.
We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.
Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.
From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.
Our trusted Pharma Intelligence brands
Scrip
27 Jun 2017
BIO International 2017 discussion: growing a biotech business.
Topic Business strategies
Pharma Consulting
27 Jun 2017
Biopharma portfolio management, commercial optimization, and R&D strategy can be tricky. We develop customized solutions to help you make better informed strategic decisions.
Medtech Insight
26 Jun 2017
Virtual reality is seeing an upsurge in use by mental health practitioners for treating conditions such as post-traumatic stress disorder.
Medtech Insight
By Frank Montana 26 Jun 2017
Meddevicetracker weekly round up
In Vivo
26 Jun 2017
The essential information in this free video comes to you from In Vivo, part of the Informa Pharma Intelligence suite of tools.
Topic Personalized Medicine
Pink Sheet
By Sue Sutter 26 Jun 2017
US FDA hands Pfizer its second complete response letter for its proposed biosimilar to Epogen/Procrit.
Topic Biosimilars
Medtech Insight
26 Jun 2017
A top reviewer in US FDA's in vitro diagnostics office offers tips to next-generation sequencing test sponsors to avoid common submission shortcomings.
Topic Personalized Medicine
Scrip
By Sten Stovall 26 Jun 2017
Flemming Ornskov says FDA approval of long-lasting ADHD therapy Mydayis.
Pink Sheet
By Anju Ghangurde 26 Jun 2017
Just months after the US FDA cleared Kisqali, Novartis appears on course to bring the breast cancer therapy to India after a key local expert panel.
Topic Cancer
Scrip
By Lucie Ellis 26 Jun 2017
AbbVie and Gilead's latest hepatitis C therapies are anticipated to win positive recommendations for approval in Europe.
Pharma Consulting
26 Jun 2017
Leading provider of strategic solutions for pharmaceutical industry professionals, Informa Pharma Consulting, has appointed Richard Veal as Global Director.
Clinical and Research Excellence
26 Jun 2017
BOSTON – June 26, 2017 – Informa’s Pharma Intelligence has today announced that the third annual Clinical and Research Excellence (CARE) Awards are now open for nominations.
Clinical and Research Excellence
22 Jun 2017
Pharma Intelligence is pleased to announce the launch of the third annual Clinical and Research Excellence (CARE) Awards.
Pink Sheet
By Kate Rawson 21 Jun 2017
Using lessons learned from the first wave of biosimilar approvals – and citing high prices in the US .
Topic Biosimilars
Pink Sheet
By Michael McCaughan 21 Jun 2017
Biosimilar sponsors are 0-3 so far in attempts to win US FDA approval for copies of Amgen’s pegfilgrastim.
Topic Biosimilars Drug approval
Pink Sheet
20 Jun 2017
Pink Sheet
20 Jun 2017
Pink Sheet
20 Jun 2017
Pink Sheet
20 Jun 2017
Scrip
19 Jun 2017
Pink Sheet
19 Jun 2017
Scrip
19 Jun 2017
Pink Sheet
19 Jun 2017
Medtech Insight
19 Jun 2017
Scrip
19 Jun 2017
Medtech Insight
19 Jun 2017
Medtech Insight
19 Jun 2017
Medtech Insight
19 Jun 2017
Scrip
19 Jun 2017
Scrip
19 Jun 2017
The industry’s gold standard for clinical trials intelligence, made by experts for experts
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Timely news and in-depth insight. Essential for anyone making commercial decisions in the pharmaceutical industry.
Key benefits:
29 Jun 2017
Webinar
12 Jul 2017 , 15:00 BST
Webinar
19 Jul 2017 , 16:00 BST
Webinar
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date